-
Product Insights
New![]()
El Romero Solar PV Park
El Romero Solar PV Park is a solar PV project located in Antofagasta, Chile. The project is owned by Acciona Energia SA and was developed by Acciona Energia SA; Avenir Solar Energy Chile SpA. The project came online in 2016. Empower your strategies with our El Romero Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sildenafil Citrate in Erectile Dysfunction
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Sildenafil Citrate in Erectile Dysfunction Drug Details:Sildenafil is a benzenesulfonamide derivative acts as vasoactive agent. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Anzurstobart in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Anzurstobart in Solid Tumor Drug Details: CC-95251 is under development for the treatment of colorectal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Azenosertib in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Azenosertib in Solid TumorDrug Details:Azenosertib (ZNC-3) is under development for the treatment solid tumors including relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Azenosertib in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Azenosertib in Solid Tumor Drug Details: Azenosertib (ZNC-3) is under development for the treatment solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Gene Therapy To Target Bcma And Cd19 For Blood Cancers And Systemic Lupus Erythematosus in Systemic Lupus Erythematosus
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Gene Therapy To Target Bcma And Cd19 For Blood Cancers And Systemic Lupus Erythematosus in Systemic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Anzurstobart in Diffuse Large B-Cell Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Anzurstobart in Diffuse Large B-Cell Lymphoma Drug Details:CC-95251 is under development for the treatment of colorectal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pritumumab in Oligodendroglioma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pritumumab in Oligodendroglioma Drug Details: Pritumumab is under development for the treatment of brain cancers...
-
Product Insights
![]()
Avenir Hldgs – The Avenir Mixed-Use Development – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Avenir Hldgs - The Avenir Mixed-Use Development - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
![]()
Juanito King – The Highline Tower by Avenir – Central Visayas
Equip yourself with the essential tools needed to make informed and profitable decisions with our Juanito King - The Highline Tower by Avenir - Central Visayas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.